Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy.
Andreas VenizelosChristina EngebrethsenWei DengJürgen GeislerStephanie GeislerGjertrud T IversenTurid AasHildegunn S AaseManouchehr SeyedzadehEli Sihn SteinskogOla MyklebostSigve NakkenDaniel VodakEivind HovigLeonardo A Meza-ZepedaPer E LønningStian KnappskogHans Petter EikesdalPublished in: Genome medicine (2022)
ClinicalTrials.gov, NCT00496795 , registered on July 4, 2007.